Riskpilot← Back to searchSign inGet full accessErconitum Oy
OYActiveY-tunnus 2060242-0Kanavanranta 9Medical specialists activities · NACE 8622Est. 20061 employees
Revenue 2024
EUR 215K
+16% vs 2023
EBITDA margin
17.2%
+2149% vs 2023
Equity ratio
78.1%
Financial strength
Net profit 2024
EUR 17K
+210% vs 2023
| Revenue | EUR 215K | +16% |
| EBITDA | EUR 37K | +2149% |
| Net profit | EUR 17K | +210% |
| Total assets | EUR 468K | -5% |
| Equity | EUR 366K | -4% |
| Employees | 1 | — |
Legal name
Erconitum Oy
Y-tunnus number
2060242-0
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
18. syyskuuta 2006
Share capital
EUR 8 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana ovat yksityislääkäripalvelut, yleislääkäripalvelut sekä lääkärin kotikäynnit. Toimialoihin kuuluu vesi- ja maakulkuneuvojen osto, myynti ja vuokraustoiminta. Myös mediapalveluiden tuottaminen kuuluu yhtiön toimialaan. Yhtiö voi omistaa, hallita, ostaa, myydä ja vuokrata kiinteistöjä, osakehuoneistoja, osakkeita ja arvopapereita omaan lukuunsa, sekä harjoittaa muuta sijoitustoimintaa.
Address
Kanavanranta 9
Phone
+3580405412741
Email
pyry.suonsivu@erconitum.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 317 | 301 | 248 | 186 | 185 | 215 |
| Staff expenses | −58 | −89 | −53 | −87 | −50 | −62 |
| EBITDA | 89 | 72 | 52 | −37 | 2 | 37 |
| Depreciation & amort. | −6 | −12 | −9 | −12 | −9 | −3 |
| EBIT | 83 | 60 | 43 | −49 | −8 | 34 |
| Net financials | 4 | 3 | 4 | 19 | −8 | −6 |
| Profit before tax | 87 | 63 | 47 | −30 | −16 | 28 |
| Tax | 17 | 12 | 10 | 0 | −0 | 11 |
| Net profit | 70 | 51 | 37 | −30 | −16 | 17 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 645 | 669 | 646 | 554 | 492 | 468 |
| Equity | 475 | 499 | 497 | 432 | 383 | 366 |
| Long-term debt | 137 | 129 | 114 | 98 | 83 | 67 |
| Short-term debt | 33 | 41 | 36 | 23 | 27 | 35 |
| Total debt | 170 | 170 | 149 | 121 | 110 | 103 |
EBITDA margin
17.2%
This company
15.8%
Market median
+9% vs market
20192024
Equity ratio
78.1%
This company
38.2%
Market median
+104% vs market
20192024
Return on equity
4.8%
This company
18.4%
Market median
-74% vs market
20192024
Net profit margin
8.1%
This company
8.1%
Market median
+0% vs market
20192024
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20192024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PS Deputy Member | Deputy Member | 2013 | — | — |
JT Audit | Audit | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Erconitum Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Päivi Sirkka Regina Suonsivu-Miettinen | Deputy Member | 0 companies |
| Jari Tapani Nurkkala | Audit | 0 companies |
| Pyry-Pekka Kalevi Suonsivu | Board of Directors | 0 companies |